Restoration of Blood Pressure after Administering Methylene Blue for Vasoplegic Syndrome, which Developed after Open Heart Surgery for Septic Infective Endocarditis -A case report - |
Lee, Sak
(Department of Thoracic and Cardiovascular Surgery, Severance Hospital, Yonsei University College of Medicine)
Bae, Mi-Kyung (Department of Thoracic and Cardiovascular Surgery, Severance Hospital, Yonsei University College of Medicine) Yi, Gi-Jong (Department of Thoracic and Cardiovascular Surgery, Severance Hospital, Yonsei University College of Medicine) Youn, Young-Nam (Department of Thoracic and Cardiovascular Surgery, Severance Hospital, Yonsei University College of Medicine) Song, Suk-Won (Department of Thoracic and Cardiovascular Surgery, Severance Hospital, Yonsei University College of Medicine) Kim, Do-Kyun (Department of Thoracic and Cardiovascular Surgery, Severance Hospital, Yonsei University College of Medicine) |
1 | Leyh RG, Kofidis T, Struber M, et al. Methylene blue: the drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass. J Thorac Cardiovasc Surg 2003;125:1426-31 DOI ScienceOn |
2 | Evora PR, Ribeiro PJ, De Andrade JC. Methylene blue administration in SIRS after cardiac operations. Ann Thorac Surg 1997;63:1212-3 DOI PUBMED ScienceOn |
3 | Mekontso-Dessap A, Houel R, Soustelle C, Kirsch M, Thebert D, Loisance DY. Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function. Ann Thorac Surg 2001;71:1428-32 DOI ScienceOn |
4 | Shanmugam G. Vasoplegic syndrome - the role of Methylene blue. Eur J Cardiothorac Surg 2005;28:705-10 DOI ScienceOn |
5 | Grayling M, Deakin CD. Methylene blue during cardiopulmonary bypass to treat refractory hypotension in septic endocarditis. J Thorac Cardiovasc Surg 2003;125:426-7 DOI ScienceOn |
6 | Maslow AD, Stearns G, Batula P, Schwartz CS, Gough J, Singh AK. The hemodynamic effects of Methylene blue when administered at the onset of cardiopulmonary bypass. Anesth Analg 2006;103:2-8 DOI ScienceOn |
7 | Taylor K. SIRS: the systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg 1996;61:1607-8 DOI PUBMED ScienceOn |
8 | Levin RL, Degrange MA, Bruno GF, et al. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery. Ann Thorac Surg 2004;77:496-9 DOI ScienceOn |